Ocular drug delivery faces strong barriers. Choosing between topical and intravitreal routes of administration shape efficacy, safety, and CMC design decisions.
- Why Improving Drug Delivery Remains A Major Opportunity In Oncology
- Crossing The Brain's Barrier: Recent Advances And What Lies Ahead
- Navigating Combination Products: Device Complexity And Software Integration
- Improving Execution Of Biological Evaluation Of Drug Delivery Devices
- DDW 2026 Signalled The Next Era Of Competitive Landscape In IBD
- From Exosomes To Nanodrugs: Advancing Therapeutic Delivery For CNS Repair
- Risk Is the Spine: What The First 100 QMSR Inspections Reveal
- Advancing Autologous Stem Cell Engineering For Diabetes And Vision Loss
ON-DEMAND WEBINARS
Discover how pharma companies can select tailored pre-filled syringes for biologics and biosimilars by aligning drug delivery needs with specialized containers and analytical services.
Launching a large molecule in one format and then switching the delivery format often transpires as a lifecycle management strategy for cost efficiency, supply chain continuity, and patient benefit.
Discover how to advance new compounds with complex chemistry through each stage of development by refining processes to give fit-for-purpose manufacturability and yields.
Succeed in combination product development by understanding the risk factors that may arise and implementing mitigation strategies that will streamline the device development process.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![West2]( "Laying Supply Chain Foundations That Bring Confidence To Compliance")
Laying Supply Chain Foundations That Bring Confidence To ComplianceCompliance with EU GMP Annex 1 requires a strategic CCS. Learn how a framework based on people, communication, process, and continuous improvement enables systematic, long-term compliance.
-
![GettyImages-1346739457-environmental-sustainability-pill-tablet-capsule-OSD-green]( "Reducing Environmental Impact At All Stages Of The Medicine Journey")
Reducing Environmental Impact At All Stages Of The Medicine JourneyExplore how utilizing technologies like AI and digital twinning can inform decision-making at the R&D stage and how to optimize the delivery of the final drug product to patients with greener logistics.
-
![blood pressure test smartwatch, wearable medical devices-GettyImages-2211444948]( "Extending The Reach Of Critical Care: Remote Sensing")
Extending The Reach Of Critical Care: Remote SensingIn emergencies, scarce data delays decisions. Remote sensing — radar, thermal, and vision — assesses patients at a distance, enabling faster triage, smarter resource use, and more informed care.
-
![West-C&G 1 - GCApp_^Vial Adapter family]( "Vial Adapter Considerations For Cell And Gene Therapy Applications")
Vial Adapter Considerations For Cell And Gene Therapy ApplicationsReview features that need to be considered to choose a vial adapter for cell and gene therapy drug products and a case study where vial adapter transfer devices have been used to extract lentiviruses.
-
![nanoparticles_updated]( "Liposome Vs. Lipid Nanoparticle: What's The Difference?")
Liposome Vs. Lipid Nanoparticle: What's The Difference?Here, we discuss the differences between nanoparticles and liposomes along with their applications in medicine.
-
![Guidelines For Selecting A Strategic Partner For Your Combination Product]( "Selecting A Strategic Partner For Your Combination Product")
Selecting A Strategic Partner For Your Combination ProductIt is imperative to choose an experienced partner that can ensure the highest quality products, minimize supply chain disruptions, and efficiently bring safe, effective drug products to patients.
-
![GettyImages-950086574-oral-solid-OSD-pill-tablet-capsule-development]( "Nanoformed API: A Superior Alternative To Solid Dispersions")
Nanoformed API: A Superior Alternative To Solid DispersionsCutting-edge nanotechnology is now emerging, able to address bioavailability challenges and deliver higher drug loads in more patient-friendly formats with fewer and smaller pills and easier regimens.
-
![West]( "Streamlining Primary Container And Device Selection With Predictive Calculations")
Streamlining Primary Container And Device Selection With Predictive CalculationsExpolore a theoretical approach to complement experimental approaches to more quickly select a packaging and delivery system for your drug product.
-
![West-1]( "Understanding Risks Of Biologic Drugs And Injectable Drug-Device Combination Products")
Understanding Risks Of Biologic Drugs And Injectable Drug-Device Combination ProductsAs the benefits of delivering biologic drugs as part of a combination product platform are realized, this self-administration trend will continue to grow. From a regulatory perspective, the use of a risk-based approach is foundational.
-
![Ready-To-Use GLP-1]( "Ready-To-Use Cartridges: Ensuring Compatibility For GLP-1-Based Drugs")
Ready-To-Use Cartridges: Ensuring Compatibility For GLP-1-Based DrugsReady-to-use cartridges for GLP-1 applications offer safe, reliable self-administration. See how they can minimize complexities and better align with the stringent demands of modern manufacturing.
TOM'S TAKES ON DRUG DELIVERY
TALKING WITH TOM VIDEOCASTS
Fran offers keen industry and technical insights exclusively on Drug Delivery Leader.
DELIVERED BY DEGRAZIO
-
![Delivered _by _DeGrazio_Logo_Color_2]( "Procuring Packaging And Delivery Systems: Single Versus Dual Sourcing")
Procuring Packaging And Delivery Systems: Single Versus Dual SourcingIn this article, Fran DeGrazio examines the trend toward dual sourcing of products, components, and materials for drug delivery packaging and systems. She outlines the key differences between single and dual sourcing and makes recommendations about using one versus the other while mitigating supply chain and product quality risk.
FREE EBOOK: COMBINATION PRODUCTS
Combination products provide significant avenues for increasing patient adherence and overall efficacy. This collection outlines the opportunity and identifies strategies for gaining regulatory approval.
